Medicine and Dentistry
Meta-Analysis
100%
Systematic Review
94%
Maturity Onset Diabetes of the Young
89%
Sodium Glucose Cotransporter 2 Inhibitor
89%
Hypoglycemia
64%
Adverse Effect
49%
Monotherapy
48%
Polyuria
39%
Urinary Excretion
39%
Inappropriate Prescribing
37%
Placebo
37%
Urinary Tract Infection
35%
Insulin Resistance
35%
middle age
34%
Hydrocortisone
29%
Combination Therapy
29%
Diabetes Mellitus in Pregnancy
29%
Pulmonary Hypertension
29%
Proton-Pump Inhibitor
29%
Glycon
29%
Connective Tissue Disease
29%
Infusion Therapy
29%
Controlled Clinical Trial
29%
Frailty
29%
Endothelin Receptor Antagonist
29%
Urinary System
29%
Genital Tract Infection
29%
Desmopressin
29%
Postural Orthostatic Tachycardia Syndrome
29%
Cushing Syndrome
29%
Cushing Disease
29%
Medicine
29%
All Cause Mortality
17%
Congestive Heart Failure
17%
Nephropathy
14%
Hypovolemia
14%
Kidney Function
14%
Odds Ratio
14%
Health Status
14%
Adverse Event
13%
Hyperglycemia
12%
Observational Study
12%
Infusion
11%
Patient with Type 2 Diabetes
9%
Cardiovascular Disease
9%
Urogenital Tract Infection
9%
Mortality Rate
9%
Random Effects Model
9%
Inferior Petrosal Sinus Sampling
8%
Renin
7%
Pharmacology, Toxicology and Pharmaceutical Science
Non Insulin Dependent Diabetes Mellitus
69%
Hypoglycemia
67%
Metformin
59%
Sodium Glucose Cotransporter 2 Inhibitor
59%
Hyperglycemia
42%
Congestive Heart Failure
39%
Observational Study
39%
All Cause Mortality
39%
Placebo
37%
Clinical Trial
35%
Random Effects Model
35%
Randomized Controlled Trial
32%
Proton Pump Inhibitor
29%
Endothelin Receptor Antagonist
29%
Hydrocortisone
29%
Pharmacokinetic
29%
Generic Drug
29%
Hemodialysis
29%
Antiinfective Agent
29%
Controlled Clinical Trial
29%
Drug Safety
29%
Multiple Chronic Conditions
29%
Diltiazem
29%
Population Study
29%
Sodium Glucose Cotransporter Inhibitor
29%
Connective Tissue Disease
29%
Addison Disease
29%
Frailty
29%
Brain Ischemia
29%
Cushing Disease
29%
Pulmonary Hypertension
29%
Methotrexate
29%
Antiviral Drug
29%
Psoriatic Arthritis
29%
Combination Therapy
29%
Aminoglycoside
20%
Adverse Drug Reaction
20%
Dipeptidyl Carboxypeptidase Inhibitor
20%
Angioneurotic Edema
20%
Monotherapy
18%
Polymyxin
14%
Ciprofloxacin
14%
Cotrimoxazole
14%
Daptomycin
14%
Ofloxacin
14%
Clindamycin
14%
Amikacin
14%
Trimethoprim
14%
Tedizolid
14%
Colistimethate
14%
Nursing and Health Professions
Hypoglycemia
69%
Meta Analysis
64%
Systematic Review
64%
Hospital Readmission
59%
Economic Evaluation
59%
Health Care
53%
Inappropriate Prescribing
34%
Statin (Protein)
29%
Proton Pump Inhibitor
29%
Cross-Sectional Study
29%
Frailty
29%
Hospitalized Older Adults
29%
Malignant Neoplasm
29%
Deprescribing
23%
Literature Review
14%
Odds Ratio
11%
Confidence Interval
11%
Cochrane Library
11%
Hydroxymethylglutaryl Coenzyme A Reductase Inhibitor
11%
Cost Effectiveness Analysis
11%
Clinical Audit
11%
Prevalence
11%
CINAHL
10%
Clinical Outcome
9%
Effect Size
9%
Potential Difference
9%
Medline
8%
Embase
8%
Treatment Outcome
7%
Model of Care
7%
Hyperglycemia
7%
Visual Analog Scale
7%
General Practitioner
5%
Geriatrician
5%